An innovative pre-clinical stage biotherapeutics company working to develop cutting-edge treatments to address vision loss from chronic ophthalmic diseases.
I’m deeply honored to be participating on the panel “Clinical Trial Design in the Era of Evolving Regulatory Guidance” this Friday evening at Clinical Trials at the Summit in Las Vegas.
Excited for the keynote “FDA - Then and Now” by my co-panelist & former @FDA Ophthalmology Chief Dr. Wiley Chambers.
Welcome to Day 2 of #ARVO2026! Visit the Annual Meeting gallery for a photo review of each day's activities in Denver. Who knows, you might even spot yourself! bit.ly/4w8tteu@ARVOinfo
ALT An exterior view of the Colorado Convention Center with a large blue bear sculpture peering inside. A digital sign reads "Welcome to ARVO 2026." Modern glass facade and nearby trees are visible.
#ARVO2026 in Denver starts today! Dive into symposia and posters, beginning 8am. Also keep track of sessions you do not want to miss with the online Meeting Planner or mobile app. Get ready for an enlightening day! bit.ly/4tAjzR8@ARVOinfo#ophthalmology#VisionResearch
ALT A large group of Annual Meeting attendees engaged in discussions around numerous poster displays in a spacious Poster Hall. Attendees are dressed in business attire. The atmosphere is bustling and collaborative.
The logo of @OptigoBio reflects our goal: reducing the burden of monthly eye injections on patients, physicians, and payers.
Our latest data shows that Optigo's platform could significantly extend the half life of current and future intravitreal treatments for #retinaldiseases.
We look forward to reconnecting with colleagues & industry peers in Zürich at #Sachs_ELSF, part of #SSLSW.
We're pleased to share updates from @OptigoBio and would welcome the opportunity to connect. Please contact us: info@optigobio.com
#OptigoBio#LifetimeBetterVision
Explore what’s next in life sciences at Access to Innovation 2026 — a day of insights and connections.
Introducing the GSK Panel: Breaking Barriers in Clinical Research.
Bryan Tennant, Lakshmi Krishnan, Stephania Manusha & Dr. Geoff Payne
Register here: lifesciencesbc.ca/event/11th…
As we look toward 2026, we remain focused on innovation and delivering lasting value for ophthalmology patients. We wish you a pleasant holiday season and look forward to continued growth in the year ahead.
Ali Ardakani
Co-Founder & CEO
Optigo Biotherapeutics Inc. (@OptigoBio)